(Q33215800)

24 July 2017

title

HLA type-independent generation of antigen-specific T cells for adoptive immunotherapy (English)

1 reference

24 July 2017

1 reference

12

Petra Reinke

1 reference

24 July 2017

Andreas Moosmann

4

0 references

Florian Kern

object named as

Florian Kern

5

0 references

Hans-Dieter Volk

11

object named as

Hans-Dieter Volk

1 reference

24 July 2017

9

Cliona M Rooney

1 reference

24 July 2017

7

Nina Babel

1 reference

24 July 2017

3

Gordon Brestrich

1 reference

24 July 2017

8

Alexa Mittenzweig

1 reference

24 July 2017

Markus H Hammer

1

1 reference

24 July 2017

Sonja Meyer

2

1 reference

24 July 2017

Lydia Tesfa

6

1 reference

24 July 2017

Wolfgang Hammerschmidt

10

1 reference

24 July 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

European Journal of Immunology

24 July 2017

published in

1 reference

24 July 2017

volume

35

1 reference

24 July 2017

issue

7

1 reference

24 July 2017

page(s)

2250-2258

1 reference

Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526230

Principles for adoptive T cell therapy of human viral diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526230

7 January 2021

Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526230

7 January 2021

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526230

7 January 2021

Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526230

7 January 2021

Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526230

7 January 2021

Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526230

7 January 2021

Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526230

7 January 2021

A novel cytolysis assay using fluorescent labeling and quantitative fluorescent scanning technology

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526230

7 January 2021

Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526230

7 January 2021

Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig–coated artificial antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526230

7 January 2021

Purification of cytomegalovirus-specific CD8 T cells from peripheral blood using HLA-peptide tetramers

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526230

7 January 2021

Generation of cytomegalovirus (CMV)-specific CD4 T cell lines devoid of alloreactivity, by use of a mixture of CMV-phosphoprotein 65 peptides for reconstitution of the T helper repertoire

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526230

7 January 2021

Adoptive therapy with CD8(+) T cells: it may get by with a little help from its friends

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526230

7 January 2021

Rapid generation of combined CMV-specific CD4+ and CD8+ T-cell lines for adoptive transfer into recipients of allogeneic stem cell transplants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526230

7 January 2021

Antigen loading of dendritic cells with whole tumor cell preparations

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526230

7 January 2021

Induction of CMV-specific T-cell lines using Ag-presenting cells pulsed with CMV protein or peptide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526230

7 January 2021

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526230

7 January 2021

Cell transfer therapy for cancer: lessons from sequential treatments of a patient with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526230

7 January 2021

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526230

7 January 2021

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526230

7 January 2021

Generation of CMV-specific T lymphocytes using protein-spanning pools of pp65-derived overlapping pentadecapeptides for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526230

7 January 2021

Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526230

7 January 2021

T-cell epitope mapping by flow cytometry

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200526230

7 January 2021

Identifiers

DOI

10.1002/EJI.200526230

1 reference

24 July 2017

1 reference